Jain Akshay B, Lai Valerie
Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, AB, Canada.
Diabetes Ther. 2024 Sep;15(9):2001-2025. doi: 10.1007/s13300-024-01628-0. Epub 2024 Jul 31.
With the increasing global incidence of diabetes mellitus, physicians may encounter more patients with acute and chronic complications of medication-induced hyperglycemia and diabetes. Moreover, medication-induced diabetes may be an important contributing factor to the high rates of diabetes, and recognizing its impact and risk is a critical step in curtailing its effect on the global population. It has long been recognized that multiple classes of medications are associated with hyperglycemia through various mechanisms, and the ability to foresee this and implement adequate management strategies are important. Moreover, different antihyperglycemic medications are better suited to combat the hyperglycemia encountered with different classes of medications, so it is critical that physicians can recognize which agents should be used, and which medications to avoid in certain types of medication-induced hyperglycemia. In this review, we will discuss the evidence behind the main classes of medications that cause hyperglycemia, their mechanism of action, specific agents that are associated with worsened glycemic control, and, most importantly, management strategies that are tailored to each specific class.
随着全球糖尿病发病率的不断上升,医生可能会遇到更多患有药物性高血糖和糖尿病急慢性并发症的患者。此外,药物性糖尿病可能是糖尿病高发病率的一个重要促成因素,认识到其影响和风险是减少其对全球人口影响的关键一步。长期以来人们已经认识到,多种类别的药物通过各种机制与高血糖有关,能够预见这一点并实施适当的管理策略很重要。此外,不同的降糖药物更适合对抗不同类别药物所导致的高血糖,因此医生能够识别哪些药物应该使用,以及在某些类型的药物性高血糖中应避免使用哪些药物至关重要。在这篇综述中,我们将讨论导致高血糖的主要药物类别背后的证据、它们的作用机制、与血糖控制恶化相关的具体药物,以及最重要的是,针对每个特定类别的管理策略。